Simulations Plus (SLP) Announces Collaboration Agreement with Top-5 Pharma Company
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it has signed a collaboration agreement with a top-5 pharmaceutical company to extend and enhance its oral cavity dosing model within its industry gold standard GastroPlus™ simulation software program.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monsanto (MON), U.S. SEC Enter $80M Settlement Over Roundup Accounting Violations
- Twitter (TWTR) Debuts New Trust & Safety Council; Aims to Protect Freedom of Expression
- Mast Therapeutics (MSTX) to Offer Common Stock And Warrants
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!